Artificial intelligence, digital health and novel therapeutic technologies are expected to drive transformation in biopharma in 2024, despite ongoing challenges in financing.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?